VC firms
With offices in London and San Francisco, Monograph bridges opportunities across North America and the UK/Europe, bringing deep experience, assets and capabilities to help life sciences company scale and succeed.
Overview
Employees
11-50
Founded date
2021
Investment Type
Venture Capital
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 19, 2023 | Maxion Therapeutics awarded £2 million Innovate UK funding to develop ion channel antibodies for “hard-to-treat” autoimmune diseases | Cambridge, UK – 19 April 2023 – Biotechnology company Maxion Therapeutics (‘Maxion’) today announced it has been awarded a prestigious GBP £2 million grant from innovate uij as part of its Biomedical Catalyst 2022 Round 2: lndustrvd ied R&... |
| Apr 19, 2023 | Maxion Therapeutics awarded £2 million Innovate UK funding to develop ion channel antibodies for “hard-to-treat” autoimmune diseases | Cambridge, UK – 19 April 2023 – Biotechnology company M ... |
| Jan 5, 2023 | ODAIA Secures $25M for AI-Driven Commercial Insights Platform for Pharma | What You Should Know: ODAIA, developers of MAPTUAL, an AI-powered commercial insights SaaS platform for pharmaceutical companies, announced it raised an oversubscribed $25 Million Series B financing round, led by Threshold Ventures and co-l... |
Reviews 0
FAQ about Monograph Capital
When was Monograph Capital founded?
Monograph Capital was founded in 2021.
What has the press written about Monograph Capital?
Parsers VC has collected 4 articles mentioning Monograph Capital, among them “Maxion Therapeutics awarded £2 million Innovate UK funding to develop ion channel antibodies for “hard-to-treat” autoimmune diseases” (Apr 19, 2023) and “Maxion Therapeutics awarded £2 million Innovate UK funding to develop ion channel antibodies for “hard-to-treat” autoimmune diseases” (Apr 19, 2023).
Is Monograph Capital still active?
Yes, Monograph Capital is active; its latest activity on Parsers VC dates from Mar 5, 2025.